GlassScriptPhysician profile
Laura Sheedy
NPI 1962821850
$7,868.63
in general payments reported to CMS, 2019-2025
25 companies · $1,705 in 2025
The $1,705 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $859 · 2022: $1,561 · 2023: $1,604 · 2024: $2,140 · 2025: $1,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,069 · Education: $380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,069.36 |
| Education | $379.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,500.87 | 2021-2025 | Tremfya |
| Abbvie INC. | $1,374.05 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $1,262.78 | 2021-2025 | |
| Ucb, INC. | $517.57 | 2021-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $372.46 | 2023-2025 | Zoryve |
| Amgen INC. | $369.73 | 2021-2025 | Otezla, Otezla |
| Sun Pharmaceutical Industries INC. | $342.16 | 2021-2025 | Ilumya |
| Incyte Corporation | $327.35 | 2021-2025 | Opzelura |
| Lilly USA, LLC | $280.96 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Dermavant Sciences, INC. | $235.13 | 2022-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $233.23 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $212.65 | 2021-2025 | |
| Leo Pharma INC. | $200.55 | 2021-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $171.33 | 2021-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $112.42 | 2021-2025 | Aklief, Oracea, Nemluvio |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.13 | 2022-2023 | |
| Springworks Therapeutics, INC. | $54.65 | 2025 | Gomekli |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $52.25 | 2021-2023 | Jublia, Arazlo |
| Organon LLC | $45.75 | 2025 | Vtama |
| Biofrontera INC. | $38.25 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.43 | 2025 | Spevigo |
| Almirall LLC | $23.18 | 2022 | |
| Epi Health, LLC | $20.56 | 2022 | |
| Kyowa Kirin, INC. | $18.72 | 2021 | |
| Lnhc, INC | $14.47 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Sheedy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.